Pharma lobbyists flood the zone in D.C., with Pfizer and Amgen leading the way

Big Pharma has taken a tongue-lashing on Capitol Hill as scrutiny over drug pricing and competition ramps up. But while executives were raked over the coals on live TV, a surge of pharma lobbyists worked overtime behind the scenes.